Appasamy Ocular Devices Profile
Key Indicators
- Authorised Capital ₹ 4.90 M
- Paid Up Capital ₹ 4.00 M
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 43.14 Cr
- Revenue Growth 60.09%
- Profit Growth 180.47%
- Ebitda 171.37%
- Net Worth 4.50%
- Total Assets -34.99%
About Appasamy Ocular Devices
Appasamy Ocular Devices Private Limited (AODPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 April 1995 and has a history of 29 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.90 M and a paid-up capital of Rs 4.00 M.
The company has closed loans amounting to ₹43.14 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravilla Narayanasamy and Senthil Rathasarathy serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33209TN1995PTC031170
- Company No.
031170
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Appasamy Ocular Devices Private Limited offer?
Appasamy Ocular Devices Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Dentist Tools, Equipment & Supplies, Dental Equipment, Metal Scrap & Waste Materials, Ferrous Metal Scrap, Forceps & Graspers, Surgical Scissors, Wire Mesh & Gratings, Steel Mesh.
Who are the key members and board of directors at Appasamy Ocular Devices?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Senthil Rathasarathy ![]() | Managing Director | 05-Apr-2024 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ravilla Narayanasamy ![]() | Director | 17-Feb-2022 | Current |
Financial Performance of Appasamy Ocular Devices.
Appasamy Ocular Devices Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.09% increase. The company also saw a substantial improvement in profitability, with a 180.47% increase in profit. The company's net worth moved up by a moderate rise of 4.5%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Appasamy Ocular Devices?
In 2022, Appasamy Ocular Devices had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹431.39 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 25.00 Cr
- Hdfc Bank Limited : 17.62 Cr
- Biotechnology Industry Research Assistance Council : 0.44 Cr
- Sundaram Finance Ltd. : 0.08 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Jan 2018 | Hdfc Bank Limited | ₹17.62 Cr | Satisfied |
05 Jan 2015 | Biotechnology Industry Research Assistance Council | ₹4.40 M | Satisfied |
21 Oct 2011 | Axis Bank Limited | ₹25.00 Cr | Satisfied |
11 Apr 2006 | Sundaram Finance Ltd. | ₹0.79 M | Satisfied |
How Many Employees Work at Appasamy Ocular Devices?
Appasamy Ocular Devices has a workforce of 1360 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Appasamy Ocular Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Appasamy Ocular Devices's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.